Treatment Updates Emergency Use Authorization granted to 2 oral antivirals for COVID-19 treatment The FDA granted Emergency Use Authorization (EUA) to Pfizer’s Paxlovid (nirmatrelvir/ritonavir) and Merck/Ridgeback’s molnupiravir –the first two oral antivirals to treat COVID-19 at home. Prior to the FDA’s ruling, the only treatment available was injected or infused antibodies. Both of the newly … Continue reading COVID-19 Updates: January 3, 2022